In the EU, which rules may still apply for now, the regulations on advertising and claims is extremely strict. They also don't really have the privatized drug market that we have... and the UK definitely not. I don't see advertising for a GBM drug is likely. Word of mouth and research will spread the word for a disease with as few options as GBM has.... advertising would not really be a good use of money.